Alphandéry, 2020 - Google Patents

The potential of various nanotechnologies for coronavirus diagnosis/treatment highlighted through a literature analysis

Alphandéry, 2020

View PDF
Document ID
5885254580725754103
Author
Alphandéry E
Publication year
Publication venue
Bioconjugate chemistry

External Links

Snippet

With the current COVID-19 outbreak, it has become essential to develop efficient methods for the treatment and detection of this virus. Among the new approaches that could be tested, that relying on nanotechnology finds one of its main grounds in the similarity between …
Continue reading at pubs.acs.org (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00

Similar Documents

Publication Publication Date Title
Alphandéry The potential of various nanotechnologies for coronavirus diagnosis/treatment highlighted through a literature analysis
Gurunathan et al. Antiviral potential of nanoparticles—can nanoparticles fight against coronaviruses?
Nasrollahzadeh et al. Nanomaterials and nanotechnology-associated innovations against viral infections with a focus on coronaviruses
Nikaeen et al. Application of nanomaterials in treatment, anti-infection and detection of coronaviruses
Cavalcanti et al. Pharmaceutical nanotechnology: which products are been designed against COVID-19?
Rashidzadeh et al. Nanotechnology against the novel coronavirus (severe acute respiratory syndrome coronavirus 2): Diagnosis, treatment, therapy and future perspectives
Jindal et al. Nanotechnology based approaches for combatting COVID-19 viral infection
Rai et al. Nanotechnology-based promising strategies for the management of COVID-19: current development and constraints
Cardoso et al. Is nanotechnology helping in the fight against COVID-19?
Mahmud et al. Advances in nanomaterial-based platforms to combat COVID-19: Diagnostics, preventions, therapeutics, and vaccine developments
Singh et al. Insights from nanotechnology in COVID-19: prevention, detection, therapy and immunomodulation
Hasanzadeh et al. Nanotechnology against COVID-19: Immunization, diagnostic and therapeutic studies
Yayehrad et al. Could nanotechnology help to end the fight against COVID-19? Review of current findings, challenges and future perspectives
Solanki et al. New insights from nanotechnology in SARS-CoV-2 detection, treatment strategy, and prevention
Balkrishna et al. Nanotechnology interventions in the management of COVID-19: prevention, diagnosis and virus-like particle vaccines
Alimardani et al. Recent Advances on Nanotechnology‐Based Strategies for Prevention, Diagnosis, and Treatment of Coronavirus Infections
Pandey et al. Architectured therapeutic and diagnostic nanoplatforms for combating SARS-CoV-2: role of inorganic, organic, and radioactive materials
Adhikari et al. Nanomaterials for diagnostic, treatment and prevention of COVID-19
Muhammad et al. Antiviral activity of nanomaterials against coronaviruses
Ghosh et al. The emerging roles of silver nanoparticles to target viral life cycle and detect viral pathogens
Upadhyay et al. Recent advancement in SARS-CoV-2 diagnosis, treatment, and vaccine formulation: a new paradigm of nanotechnology in strategic combating of COVID-19 pandemic
Muthiah et al. Nanotechnology Toolkit for Combating COVID‐19 and Beyond
Raja et al. SARS-CoV-2 and its new variants: a comprehensive review on nanotechnological application insights into potential approaches
Kamaraj The perspective on bio-nano interface technology for covid-19
Albaz et al. Nanotechnology-based approaches in the fight against SARS-CoV-2